Here’s why Greater Cincinnati firm Airway Therapeutics just raised $6.3M


Story excerpt provided by Cincinnati Business Courier.

Written by Barrett J. Brunsman.

Airway Therapeutics, a Sharonville biotechnology company, has raised $6.3 million in bridge financing from new and existing investors to help develop a way to prevent and treat lung disease in premature babies.

The firm is developing a protein replacement therapy called AT-100, which is based on research conducted by Dr. Jeffrey Whitset at Cincinnati Children’s Hospital Medical Center.

Click here to read the complete article.

Originally published March 7, 2017.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: